Researchers at the U.S. Centers for Disease Control and Prevention have reported that a deadly drug-resistant strain of bacteria that emerged in the United States quickly took hold amid the COVID-19 pandemic, acquiring even more drug resistance.
yeast white ears Since it was first reported in the United States in 2016, it has been considered an “urgent threat”, the highest level of concern by the CDC. Yeast lurk in healthcare settings, preying on vulnerable patients and causing invasive infections with a fatality rate of between 30. to 60 percent.
In 2019, before the pandemic began, 17 states and Washington DC reported a total of 476 clinical cases. But in 2020, eight more states reported their first cases, and the number of clinical cases nationwide increased by 59% to 756. In 2021, 28 states will be affected and the number of clinical cases will nearly double to 1,471. Asymptomatic cases detected in patient screening also surged amid the pandemic, tripling from his 1,310 cases in 2020 to his 4,041 cases in 2021. The data were published Monday in the Annals of Internal Medicine.
“The rapid rise and geographic spread of cases is a concern and drives the need for continued surveillance, increased laboratory capacity, faster diagnostic testing, and adherence to proven infection prevention and control. emphasized,” he said in a statement.
But its spread wasn’t the only worrying aspect of the yeast’s pandemic activity. It also improved drug resistance. Before the pandemic, six patients developed infections resistant to the first-line antifungal drug echinocandin, but in 2021 alone, he had 19 such cases. Similarly, before the pandemic, there were only four reports of pan-resistant infections. That is, the fungus was resistant to all available drugs. In 2021, there were 7 patients with pan-resistant infections.
Before the pandemic, echinocandin-resistant and pan-resistant cases appeared to have occurred independently in patients amid ongoing therapy. However, in the 2021 cases, there was evidence of two outbreaks, an echinocandin-resistant strain and a bread-resistant strain with human-to-human transmission.
“The timing of this has increased C. ear Findings from the spread and public health surveys suggest that it may have been exacerbated by the pandemic-related burden on healthcare and public health systems,” Lyman and colleagues concluded in their study.
CDC researchers believe staff and personal protective equipment shortages, changes in patient movement, and increased use of antibiotics may be contributing to the problem. They also speculated that while certain infection control measures were stepped up during the pandemic, other measures, such as environmental disinfection, may have failed along the way, which may have exacerbated the spread. They called for renewed efforts to curb contagion. “C. ear The surprising rise during the pandemic “provides motivation to refocus on the basics of public health to prevent disease and save lives.”
